CDXS
Codexis, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.45
+2.11%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.90x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.82x
- Price / sales
- 2.04x
- Price / cash flow
- -15.26x
Enterprise value
- Enterprise value
- $176.5M
- EV / sales
- 2.27x
- EV / EBITDA
- -8.16x
- EV / EBIT
- -7.27x
- Market cap
- $158.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026